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ABSTRACT The 5-HT3 receptor belongs to a family of therapeutically important neurotransmitter-gated receptors whose
ligand binding sites are formed by the convergence of six peptide loops (A-F). Here we have mutated 15 amino acid residues in
and around loop B of the 5-HT3 receptor (Ser-177 to Asn-191) to Ala or a residue with similar chemical properties. Changes in
[3H]granisetron binding afﬁnity (Kd) and 5-HT EC50 were determined using receptors expressed in human embryonic kidney 293
cells. Substitutions at all but one residue (Thr-181) altered or eliminated binding for one or both mutants. Receptors were
nonfunctional or EC50 values were altered for all but two mutants (S182T, I190L). Homology modeling indicates that loop B
contributes two residues to a hydrophobic core that faces into the b-sandwich of the subunit, and the experimental data indicate
that they are important for both the structure and the function of the receptor. The models also show that close to the apex of the
loop (Ser-182 to Ile-190), loop B residues form an extensive network of hydrogen bonds, both with other loop B residues and
with adjacent regions of the protein. Overall, the data suggest that loop B has a major role in maintaining the structure of the
region by a series of noncovalent interactions that are easily disrupted by amino acid substitutions.
INTRODUCTION
The 5-HT3 receptor is a Cys-loop receptor, which plays a role
in synaptic transmission in both the central and peripheral
nervous systems (1). These proteins consist of ﬁve symmetri-
cally arranged subunits; each subunit has a large extracellular
N-terminal domain that is responsible for ligand binding, four
transmembrane domains (M1–M4) that surround a central ion
conducting pore, and a large intracellular loop that inﬂuences
channel conductance and mediates the actions of intracellular
messengers. The ligand binding site is at the interface of two
adjacent subunits and is formed by the convergence of three
amino acid loops (A–C) from the ‘‘principal’’ subunit and three
b-strands (D–F) from the ‘‘complementary’’ subunit (2).
Structural insight of this region has been gained from high
resolution structures of homologous acetylcholine binding
proteins (AChBPs), and nACh and bacterial receptors (2–7),
and speciﬁc interactions between amino acid residues and a
range of 5-HT3 receptor ligands have been identiﬁed within
loops A–F (8–11). Using structures of AChBP derived from
crystals, and from cryo-electron microscopy data of the nACh
receptor, a number of Cys-loop homology models have been
published; the recent high resolution structure of a nACh
receptor subunit has conﬁrmed the accuracy of such models
for the nACh receptor (6). For other receptors, however,
sequence identity is only in the region of 10–20% and ex-
perimental evidence is required to support the structural ac-
curacy of these models at the molecular level. Here we
explore the roles of each residue of loop B, as the speciﬁc
functions of the majority of these residues are currently un-
known. The data from extensive mutagenesis, binding and
functional studies reveal the importance of these residues and
also provide a structural explanation for their critical roles.
EXPERIMENTAL PROCEDURES
Materials
All cell culture reagents were obtained from Gibco BRL (Paisley, UK),
except fetal calf serum which was from Labtech International (Ringmer,
UK). [3H]granisetron (63.5 Ci/mmol) was from PerkinElmer (Boston, MA).
All other reagents were of the highest obtainable grade.
Cell culture
Human embryonic kidney (HEK) 293 cells were maintained on 90 mm tissue
culture plates at 37C and 7% CO2 in a humidiﬁed atmosphere. They were
cultured in DMEM:F12 (Dulbecco’s modiﬁed Eagle’s medium/Nutrient Mix
F12 (1:1)) with GlutaMAX I media containing 10% fetal calf serum. For
radioligand binding studies cells in 90 mm dishes were transfected using
calcium phosphate precipitation at 80–90% conﬂuency and incubated for
3–4 days before use; optimization of the original method (12) by Jordon (13)
resulted in increased levels of binding, which has allowed us to obtain
binding parameters for mutant receptors that in the past have been expressed
at levels too low to measure (e.g., W183Y and H185A). For functional
studies, cells were transfected by electroporation using the AMAXA system
(Amaxa GmbH, Cologne, Germany), plated on 96 well plates and incubated
1–2 days before assay.
Site-directed mutagenesis
Mutagenesis reactions were performed using the method described by
Kunkel (14) using 5-HT3A receptor subunit cDNA (Accession: AY605711)
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in pcDNA3.1 (Invitrogen, Paisley, UK) as described previously (15). A silent
restriction site was incorporated into each primer to assist rapid identiﬁcation.
Radioligand binding
This was undertaken as previously described with minor modiﬁcations (15).
Brieﬂy, transfected HEK293 cell membranes were incubated in 0.5 ml
HEPES buffer containing the 5-HT3 receptor antagonist [
3H]granisetron
(0.1–40 nM). Nonspeciﬁc binding was determined using 1 mM quipazine.
Incubations were terminated by ﬁltration, thus limiting our determination of
Kd values to#10 nM, as separation of bound from free ligand would be too
slow to determine Kd values greater than this (16). Data were analyzed
by iterative curve ﬁtting (Prism v3.0, GraphPad Software, San Diego, CA)
according to the equation: B ¼ (Bmax 3 [L])/(K 1 [L]), where B is bound
radioligand, Bmax is maximum binding at equilibrium, K is the equilibrium
dissociation constant, and [L] is the free concentration of radioligand. Values
are presented as mean 6 SE. Statistical analysis was performed using
ANOVA in conjunction with a Dunnett’s post test.
Immunoﬂuorescence
This was as described previously (17). Brieﬂy, transfected cells were ﬁxed
(4% paraformaldehyde) and incubated overnight at 4C in pAb120 at 1:1000
in Tris-buffered saline (0.1 M Tris pH7.4, 0.9 % NaCl). Biotinylated anti-
rabbit IgG (Vector Laboratories, Burlingame, CA) and ﬂuorescein isothio-
cyanate avidin D (Vector Laboratories) were used to detect bound antibody
as instructed by the manufacturer. Coverslips were mounted in Vectashield
HardSet mounting medium (Vector Laboratories). Immuno-ﬂuorescence was
observed using an UltraVIEW LCI Confocal Imaging System (PerkinElmer).
FlexStation analysis
This technique uses ﬂuorescent voltage-sensitive dyes to detect changes
in the membrane potential and has been used to examine a range of ion
channels including 5-HT3 receptors (19,20). The methods were as previously
described (19). Brieﬂy, ﬂuorescent membrane potential dye (Molecular
Devices, Wokingham, UK) was diluted in Flex buffer (10 mM HEPES, 115
mM NaCl, 1 mM KCl, 1 mM CaCl2, 1 mMMgCl2, 10 mM glucose, pH 7.4)
and added to transfected cells grown on a 96-well plate. The cells were in-
cubated at room temperature for 45 min and then ﬂuorescence was measured
in a FlexStation (Molecular Devices) every 2 s for 200 s. Control (Flex
buffer) or 5-HT (0.001 mM–1.0 mM) was added to each well after 20 s. The
percent change in ﬂuorescence was calculated as F (peak ﬂuorescence) mi-
nus Fmin (baseline ﬂuorescence at 20 s) divided by Fmax (peak ﬂuorescence at
30 mM 5-HT). Concentration-response data were ﬁtted to the four-parameter
logistic equation, F ¼ Fmin1ðFmax  FminÞ=ð1110ðlogðEC50½AÞ3nHÞ; where
Fmax is the maximum response, Fmin is the baseline ﬂuorescence, [A] is the
log concentration of agonist, and nH is the Hill coefﬁcient, using Prism
software (GraphPad). EC50 values determined using this technique are often
slightly lower than values determined using electrophysiological studies as
different phenomena are being measured: For electrophysiological studies,
EC50 values represent the agonist concentration required to open 50% of
channels, whereas in ﬂuorescent studies they represent the agonist concen-
tration required to depolarize the membrane potential to 50% of its original
value. However, relative values for different mutant 5-HT3 receptors are the
same, and as cellular events are triggered by changes in membrane potential,
this may be a more accurate indication of the ligand potency in vivo (19).
Modeling
This was performed as described previously (9,21). Three-dimensional
models of the extracellular region of the 5-HT3 receptor were built using
MODELER 6v2 (22) based on the crystal structure of AChBP in different
states; unbound (Protein Data Bank (PDB) ID 2byn), agonist bound (car-
bomylcholine, PDB ID 1uv6 and epibatidine, PDB ID 2byq) and antagonist
bound (2-methyllcaconitine, PDB ID 2byr and a-cobratoxin, PDB ID 1yi5).
Models were energy minimized in SYBYL v6.8 using the AMBER force ﬁeld
(23).Models and predicted hydrogen bondswere viewedusingPyMOLv0.98.
RESULTS
Effects of mutations
All 15 amino acids within a contiguous sequence of the 5-HT3A
receptor subunit (Fig. 1)weremutated to either Ala or an amino
acid with properties similar to the wild-type amino acid
(subsequently referred to as a conserved amino acid change).
Mutant receptors were characterized using [3H]granisetron
binding to explore changes in the ligand binding site (Table 1,
Fig. 2), and 5-HT induced changes in membrane potential
were measured using a voltage-sensitive ﬂuorescent dye
(Table 2, Fig. 2). Wild-type receptors had a [3H]granisetron
binding afﬁnity (Kd) of 0.5 nM (n ¼ 11) and 5-HT EC50 of
0.24 mM (n¼ 12), values that are similar to those previously
published using the same techniques (15,24,25).
Alanine mutations
Amino acid substitutions to Ala revealed signiﬁcant changes
in [3H]granisetron binding afﬁnities for 9 of the 15 residues
(Table 1). At Phe-180, Trp-183, Asp-189, Ile-190 and Asn-
191, substitution with Ala eliminated any measurable bind-
ing, indicating a particularly important role for these residues.
Data from the functional assay indicated a more signiﬁcant
effect on function as only 5 of the Ala substitutions were
functional (T181A, W183A, L184A, T186A and I187A),
and each of these displayed a signiﬁcant increase in the EC50
when compared to wild-type responses.
Conserved mutations
Amino acid substitutions with conserved residues showed
signiﬁcant changes in [3H]granisetron binding afﬁnities for
10 of the 15 residues (Table 1). Five of these were identical to
residues that had displayed sensitivity to Ala mutation (Leu-
178, Phe-180, Trp-183, Asp-189, Asn-191). For the re-
maining ﬁve conserved mutations that displayed altered Kd
values (Ser-177, Ser-182, His-185, Thr-186, Gln-188),
there was no corresponding change in afﬁnity for the Ala
mutants, indicating that it was not the chemical character-
istics of the residue that was critical at these positions.
Mutations at Leu-178, Gln-188 and Asp-189 caused com-
plete ablation of [3H]granisetron binding. In the functional
assay ﬁve conserved mutations were functional (S182T,
W183Y, L184I, I187L, I190L). Three of these displayed
smaller increases in EC50 than their Ala counterparts
(W183Y,L184I, I187L),whereas S182T and I190Lhad values
that were not signiﬁcantly different to wild-type receptors.
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Immunocytochemistry
For mutants that were classiﬁed as having no speciﬁc radio-
ligand binding, cell surface expression was studied using
immunoﬂuorescence and confocal microscopy. Fig. 3 shows
that of the eight mutants, four were not expressed at the cell
surface (F180A, Q188N, D189A and I190A). The remaining
mutants (L178I, W183A, D189E and N191A) all showed a
distinct halo of ﬂuorescence at the cell surface, indicating that
the receptors were correctly assembled and trafﬁcked to the
plasma membrane.
Loop B modeling
To gain further insight into the possible orientations and in-
teractions of loop B residues, a range of homology models
were constructed based on AChBP crystal structures that
FIGURE 1 Location of the amino acid
residues examined in the current study.
(A) Two adjacent subunits (principal and
complementary), showing the positions
of the six binding loops A-F. (B) The
amino acid sequence for the extracellular
domain of the murine 5-HT3A receptor
(accession No. Q6J1J7), aligned with
AChBP isolated from Lymnaea stagnalis
(P58154) and the nACh receptor a1 sub-
unit (P02710). The residues examined
are highlighted as white text on a black
background. Loop F residues that we
have reported on previously are high-
lighted aswhite text on a gray background
(25). The six binding loops are indicated
by black lines above the text. The posi-
tions of b-sheets are shown by gray lines
beneath the text. Numbering of residues
and structural features are taken from the
AChBP protein crystal structure (3).
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were either unbound or bound by different ligands. The
lowest energy states for the models are shown in Fig. 4, A–E,
and the carbon backbones for each of these are overlaid in
Fig. 4 F. Loop B is similar in each of these models, sug-
gesting that regardless of the bound ligand, the position of the
loop and the orientations of the side-chains remains relatively
unaltered.
The models indicate that there is a hydrophobic core be-
tween the inner and outer b sheets (Fig. 5, A and B). They
also predict an extensive network of hydrogen bonds, both
between loop B and adjacent regions, and within the B loop
itself (Fig. 5, C and D). In the ﬁrst group, the b-strand of
loop B is stabilized by hydrogen bonds between the back-
bones of residues from Leu-178 to His-185, and the adjacent
anti-parallel strands of b4 and b10, and the backbones of
Asp-189 and Asn-191 form hydrogen bonds with the back-
bones of Thr-64 and Val-66 in the adjacent b1-strand. The
second group includes the side-chains of residues His-185,
Gln-188 and Asp-189 which stabilize a tight b7-b8 turn at
the top of loop B. Our homology models predict that amino
acid substitutions in this region would disrupt this hydrogen
bonding network (Fig. 5, E–H).
DISCUSSION
This study shows that the 5-HT3 receptor loop B is extremely
sensitive to amino acid changes; our data show that substi-
tutions of most of the residues from Ser-177 to Asn-191 have
a signiﬁcant effect on [3H]granisetron binding and 5-HT
evoked currents. Loop B in all Cys-loop receptors has long
been known to play an important role in receptor function,
but it was surprising that so many of the residues in this re-
gion were sensitive to amino acid substitution. A possible
explanation for these data is provided by our homology
models, which show that many of these residues could sta-
bilize the structure of the region through hydrophobic inter-
actions and hydrogen bonds.
FIGURE 2 Example data for receptor function and radioligand binding at
wild-type and mutant receptors. (A) Channel function was measured using a
voltage-sensitive ﬂuorometric dye on a FlexStation. Values from a series of
experiments were normalized, averaged and ﬁtted with a four-parameter
logistic equation. The calculated EC50 values are shown in Table 2. (B) Kd
values were estimated using the 5-HT3 antagonist [
3H]granisetron. The
examples show binding for single experiments, ﬁtted with a one site binding
equation. Kd values for a series of experiments were averaged for each
mutant, and are presented in Table 1.
TABLE 2 Functional effects of Ala and conserved
substitutions at the 5-HT3 receptor
Alanine
mutant
pEC50
Mean 6 SE
EC50
(mM) n
Conserved
mutant
pEC50
Mean 6 SE
EC50
(mM) n
Wild-type 6.62 6 0.06 0.24 12 Wild-type 6.62 6 0.06 0.24 12
S177A NR* — 4 S177T NR* — 4
L178A NR* — 4 L178I NR* — 4
T179A NR* — 4 T179S NR* — 4
F180A NR* — 4 F180Y NR* — 4
T181A 5.86 6 0.08* 1.38 4 T181S NR* — 6
S182A NR* — 4 S182T 6.21 6 0.07 0.62 4
W183A 4.40 6 0.11* 39.8 6 W183Y 5.28 6 0.26* 5.25 6
L184A 4.47 6 0.07* 33.9 4 L184I 5.47 6 0.17* 3.39 4
H185A NR* 4 H185N NR* — 4
T186A 4.24 6 0.03* 57.5 6 T186S NR* — 4
I187A 4.65 6 0.07* 22.4 4 I187L 5.48 6 0.10* 3.31 4
Q188A NR* 4 Q188N NR* — 4
D189A NR* 4 D189E NR* — 4
I190A NR* 4 I190L 6.33 6 0.01 0.47 4
N191A NR* 4 N191Q NR* — 4
*Signiﬁcantly different to wild-type (ANOVA with Dunnett’s post test: p,
0.05). NR, No response.
TABLE 1 Effects of Ala and conserved substitutions on
[3H]granisetron binding afﬁnities at the 5-HT3 receptor
Alanine
mutant
pKd (nM)
Mean 6 SE
Kd
(nM) n
Conserved
mutant
pKd (nM)
Mean 6 SE
Kd
(nM) n
Wild-type 9.30 6 0.12 0.5 11 Wild-type 9.30 6 0.12 0.5 11
S177A 9.23 6 0.26 0.7 5 S177T 7.86 6 0.09y 14* 3
L178A 8.02 6 0.09y 10 4 L178I NBy — 4
T179A 8.55 6 0.09y 3.2 8 T179S 9.33 6 0.22 0.5 7
F180A NBy — 5 F180Y 8.19 6 0.08y 6.5 3
T181A 9.38 6 0.18 0.4 7 T181S 9.15 6 0.11 0.7 4
S182A 9.06 6 0.10 0.9 6 S182T 8.71 6 0.03y 1.9 8
W183A NBy — 6 W183Y 8.38 6 0.10y 4.2 6
L184A 8.42 6 0.10y 4.1 4 L184I 9.12 6 0.03 0.8 6
H185A 8.86 6 0.11 1.4 5 H185N 8.45 6 0.07y 3.5 5
T186A 9.26 6 0.06 0.6 9 T186S 8.17 6 0.06y 6.8 4
I187A 7.90 6 0.04y 13* 4 I187L 8.90 6 0.14 1.3 8
Q188A 9.22 6 0.15 0.6 7 Q188N NBy — 4
D189A NBy — 4 D189E NBy — 7
I190A NBy — 5 I190L 8.93 6 0.02 1.2 4
N191A NBy — 5 N191Q 8.20 6 0.11y 6.3 4
ySigniﬁcantly different when compared to wild-type (ANOVA with
Dunnett’s post test: p , 0.05). NB, No binding or Kd values $ 10 nM,
which is the resolution of the technique (16); thus values obtained that are
.10 nM (*) may be inaccurate.
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Loop B is a stable, static structure
Comparing a range of homology models based on AChBP
bound to different agonists (which are presumed to represent
the open state of the receptor), and antagonists (the closed
state), shows that loop B is similarly positioned in each of the
models. This indicates that there is little or no movement of
this loop between the open and closed states, suggesting a
stable and static structure that does not change conformation
when ligands bind. Our homology models indicate that loop
B residues could play an important role in stabilizing the
structure of the whole region, as many loop B residues con-
tribute to a global network of noncovalent interactions. In
agreement, a similar homology-based study has found that
distances between Trp-183 residues of adjacent 5-HT3 sub-
units were comparable regardless of the AChBP template
used (25). Data from previous studies also indicate that this
region of the protein has an important structural role in ho-
mologous receptors. For example, in the nACh receptor the
loop B residue Lys-145 (equivalent to Thr-179 in the 5-HT3
receptor) has been shown to form a salt-bridge with Asp-200
(Glu-236 in 5-HT3), and is proposed as one of a number of
strong interactions that stabilize the binding region in this
receptor (26). We must, of course, be cautious when using
bound AChBP structures as templates for open and closed
states of the receptor, but comparisons with nACh receptor
structures and molecular dynamic simulations indicate they
are reasonably accurate (3,5,6,27). This observation is further
supported by the more recent structure determination of a
homologous prokaryotic ion channel (7).
Loop B contributes to a hydrophobic core
Our modeling data indicate that in each subunit there is a
central hydrophobic core formed by the converging side
chains of residues distributed throughout the 5-HT3 receptor
subunit sequence. The residues are mostly located in the in-
ner and outer b-sheets comprising the b-sandwich of the
extracellular part of the subunit, and their side chains all point
into the interior of the b-sandwich (see Figs. 1 and 5). Two
of these residues are contributed by loop B, and these are
surrounded by other hydrophobic residues; Leu-178 is sur-
rounded by Ile-127, Phe-130, Phe-180 and Phe-239, whereas
Phe-180 is surrounded by Val-70, Tyr-91, Ile-125, Ile-127,
Leu-178 and Phe-239. In total there are 16 hydrophobic
residues within 5 A˚ of Leu-178 and Phe-180 (Fig. 5). This
region may be critical for receptor folding, as hydrophobic
regions are usually the ﬁrst to form, and indeed our data
suggest that substituting Phe-180 for Ala prevents correct
assembly and targeting of the receptor. Tyr-91 and Phe-130
have also been proposed to play a role in assembly and/or
targeting (15,28). We suggest, therefore, that this hydrophobic
region is important for the correct folding and assembly of the
5-HT3 receptor, and as 15 of the 16 hydrophobic residues
align with hydrophobic residues across the entire Cys-loop
family, this region probably has a similar role in all Cys-loop
receptors.
Our data also suggest that this region has a role in receptor
function. The mutations L178A and F180Y both yield re-
ceptors that bind antagonist, indicating that these receptors
are correctly assembled and targeted, and their binding sites
FIGURE 3 Cell surface expression of mutant 5-HT3 receptors. Typical
images of wild-type and mutant receptors revealed by immunoﬂuorescent
labeling of nonpermeabilized transfected HEK 293 cells using a 5-HT3-
speciﬁc antisera (18). Scale bar, 25 mm.
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FIGURE 4 Homology models showing
the amino acid backboneof the loopB region
of the 5-HT3 receptor. (A)Unbound structure
(modeled fromAChBPwith no ligand, PDB
ID2byn). (B)Agonist bound, (modeled from
AChBP with carbomylcholine, PDB ID
1uv6). (C) Agonist bound, (modeled from
AChBPwith epibatidine, PDBID2byq). (D)
Large antagonist bound (modeled from
AChBP with a-cobratoxin, PDB ID 1yi5).
(E) Small antagonist bound, (modeled from
AChBP with 2-methyllcaconitine, PDB ID
2byr) (F) Overlays of the modeled loop B
backbones from A–E compiled with Swiss-
PdbViewer ‘‘magic ﬁt’’, using residues Ser-
177 to Asn-191 as a reference point.
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FIGURE 5 Models of the loop B re-
gion of the 5-HT3 receptor. Side (A) and
top (B) views of the hydrophobic core of
theb-sandwich around Leu-178 and Phe-
180. Loop F and a short stretch between
the N-terminus andb1 have been omitted
for clarity. Inner b-sheets in aquamarine,
outer b-sheets in pink. Hydrophobic res-
idues within 5 A˚ of Leu-178 and Phe-180
are rendered in stick representation and
color coded according to the correspond-
ing b-sheets. This hydrophobic core in-
cludes Ile-68, Val-70, Met-72, Leu-85,
Ile-89, Tyr-91, Ile-125, Ile-127, Phe-130,
Leu-158, Leu-178, Phe-180, Ile-192,
Met-237, Phe-239, and Val-241. The hy-
drophobic nature of these residues is
conserved across the Cys-loop family
(see Fig 1). (C) The distribution of poten-
tial hydrogen bonds between loop B and
adjacent regions. (D) Hydrogen bonds
between residues within loop B. Hydro-
gen bonds that may stabilize the b7-b8
turn are shown inE, andmutation of these
residues (F–H) could disrupt this pattern.
Hydrogen bonds in this ﬁgure were pre-
dicted, and are visualized, using PyMOL
v 0.98.
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are intact. However they do not function. We propose that
speciﬁc hydrophobic interactions in this part of loop B are a
critical component of a hydrophobic core, where weak and
easily interchangeable interactions are necessary for the lat-
eral movement of the outer and inner b-sheets when a ligand
binds (a proposed step in the transduction pathway that ul-
timately leads to pore opening (29)).
Loop B contributes to receptor gating
In addition to the gating role played by residues in the hy-
drophobic core, we propose that other amino acids in loop B
also have a signiﬁcant role in channel function. One of these
residues is Leu-184 which displays an ;10-fold increase in
EC50 with a conservative Ile substitution, but shows very
little change in antagonist binding afﬁnity, as previously re-
ported (9). EC50 is constituted from both agonist afﬁnity and
functional efﬁcacy. The agonist afﬁnity can be modiﬁed by
mutations that cause a structural change in the binding site,
or when an agonist-speciﬁc binding residue is altered. The
antagonist binding data show there is no structural change in
the binding site with L184I mutant receptors, and the mod-
eling data face Leu-184 away from the binding pocket; thus it
is unlikely to be an agonist-speciﬁc ligand binding residue.
The data therefore support a role for this residue in the con-
formational changes that follow, or are concomitant with,
ligand binding, and that ultimately result in channel opening.
In support of this hypothesis the adjacent residue Trp-183,
which has been shown to be involved in agonist binding (30–
33), is located facing into the binding pocket in the model,
and the mutation W183Y results in a similar fold change in
antagonist afﬁnity and EC50, suggesting it is primarily the
afﬁnity change that causes the change in EC50.
Our models suggest a mechanism by which Leu-184 could
be involved in channel opening: via hydrogen bonds with the
adjacent b-sheet of loop A. There is evidence that loop A
plays a dynamic role during receptor gating and it has been
proposed that it acts as a ‘‘latch’ that controls this process in
the nACh receptor (20). In addition, reorientations in this
region have been shown with molecular dynamic studies
(27). Our data suggest that a small residue at position 184 is
much less favorable than a larger one, and we propose that to
allow movement, Leu-184 may function as a ‘spacer’ resi-
due, holding loop B at an optimal distance from loop A and
thereby allowing movement of the latter. Similarly, ‘spacer’
residues may be important to allow movement of loop C, as a
bulky hydrophobic side chain was preferred at position 187
(loop B), and our homology models suggest van der Waals
contacts between the side chain of Ile-187 and residues
within the b9 and b10 strands (loop C) of the same subunit.
Thus Ile-187 may sterically oppose the b9 and b10 strands
and thereby assure the mobility of loop C. We propose that
loop B forms a rigid frame around which loops A and Cmove.
Other residues that may play a role in channel function are
Thr-179, Thr-181, Ser-182, His-185 and Thr-186 as mutation
of all of these signiﬁcantly affected agonist-mediated effects,
but neither Ala nor conserved mutations caused major
changes in the antagonist binding afﬁnity; the latter results
indicating the receptors are correctly assembled. However,
loss of the backbone hydrogen bonding between these resi-
dues and the adjacent b-sheets, as indicated in the homology
models, may prevent efﬁcient opening of the channel. It
should also be noted that in previous studies H185A has been
reported as nonbinding, a difference that is likely to reﬂect the
very low levels of expression (;20-fold less than wild-type)
that we observed for this mutant (11). Binding afﬁnities for
Thr-179, Ser-182 and Thr-186 mutants are almost identical to
those shown elsewhere (9).
Our homology models also suggest that there are hydrogen
bonds contributed by residues His-185 to Asn-191 which
may be important for stabilizing the b7 - b8 turn; substitution
of residues that signiﬁcantly disrupt this series of bonds
(Q188, D189 and I190; Fig. 5, G and H) results in receptors
that are not folded, assembled and/or targeted correctly.
Substitutions that permit the expression of cell-surface re-
ceptors, possibly because they disrupt fewer hydrogen bonds
(such as in H185A), may result in low levels of expression
or non functional receptors. We propose that a rigid b7-b8
turn is critical for efﬁcient receptor expression and function.
Asp-189 may also have a role in subunit-subunit interactions,
similar to the equivalent residue (Glu-149) in AChBP (3,11).
In our 5-HT3 homology models Asp-189 is in close prox-
imity to the basic side chains of Lys-112 on the comple-
mentary subunit and a highly conserved Arg-55 on the same
subunit, and there is the potential to form a salt bridge here,
an interaction that would explain why substitution of this
residue was especially sensitive; it was the only residue where
both Ala and conserved amino acid substitutions yielded non
binding receptors.
CONCLUSIONS
We have demonstrated that residues from the 5-HT3 receptor
loop B region have a major inﬂuence on binding and function.
These data can be explained by our model, which indicates
that noncovalent interactions within and between loop B and
neighboring residues, both in the binding region and within the
b-sandwich structure of the subunit, are vital for the integrity
of the binding site and for the dynamic mobility of structural
elements involved in the gating process.
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